OSTEOPOROSIS INTERNATIONAL

metrics 2024

Connecting Researchers for a Healthier Tomorrow

Introduction

OSTEOPOROSIS INTERNATIONAL, published by SPRINGER LONDON LTD, stands at the forefront of research in the field of bone health and metabolic disorders, specifically focusing on osteoporosis and related conditions. With an ISSN of 0937-941X and impressive ranking in the Q1 category of both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, this journal ranks 47th out of 244 in its category, placing it solidly within the top 20% of its field, according to Scopus metrics. The journal, active since 1990, aims to foster a deep understanding of osteoporosis through high-quality research articles, reviews, and clinical insights that are pivotal for healthcare professionals, researchers, and students alike. Although it does not offer open access, users can expect rigorous peer-reviewed content that significantly contributes to the advancement of knowledge in osteoporosis prevention, diagnosis, and treatment. With a dedicated readership and a commitment to excellence, OSTEOPOROSIS INTERNATIONAL plays a vital role in shaping the future of bone health research.

Metrics 2024

SCIMAGO Journal Rank1.11
Journal Impact Factor4.20
Journal Impact Factor (5 years)4.30
H-Index192
Journal IF Without Self4.20
Eigen Factor0.01
Normal Eigen Factor2.90
Influence1.26
Immediacy Index0.80
Cited Half Life9.20
Citing Half Life8.00
JCI0.92
Total Documents6555
WOS Total Citations19068
SCIMAGO Total Citations79582
SCIMAGO SELF Citations7767
Scopus Journal Rank1.11
Cites / Document (2 Years)3.40
Cites / Document (3 Years)3.44
Cites / Document (4 Years)3.50

Metrics History

Rank 2024

Scopus

Endocrinology, Diabetes and Metabolism in Medicine
Rank #47/244
Percentile 80.74
Quartile Q1

IF (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 40/186
Percentile 78.80
Quartile Q1

JCI (Web Of Science)

ENDOCRINOLOGY & METABOLISM
Rank 53/186
Percentile 71.51
Quartile Q2

Quartile History

Similar Journals

Therapeutic Advances in Musculoskeletal Disease

Advancing Knowledge in Musculoskeletal Health
Publisher: SAGE PUBLICATIONS LTDISSN: 1759-720XFrequency: 1 issue/year

Therapeutic Advances in Musculoskeletal Disease is a premier, peer-reviewed journal published by SAGE Publications Ltd, focusing on the latest advancements in the understanding and treatment of musculoskeletal disorders. Since becoming an Open Access journal in 2019, it has significantly broadened its reach, providing researchers, clinicians, and practitioners with unfettered access to high-quality studies and reviews from 2009 to 2024. With an impressive impact factor reflected by its Q1 rank in Orthopedics and Sports Medicine and Q2 rank in Rheumatology for 2023, the journal occupies a critical position within its field. Ranked #31 out of 321 in Orthopedics and Sports Medicine and #17 out of 73 in Rheumatology on Scopus, it emphasizes both the clinical and scientific aspects of musculoskeletal health. This journal serves as a vital resource for advancing knowledge, encouraging collaboration, and fostering innovative treatment methods within the musculoskeletal community.

JBMR Plus

Advancing knowledge in bone health and metabolism.
Publisher: WILEYISSN: Frequency: 12 issues/year

JBMR Plus, published by Wiley, is a leading open-access journal dedicated to advancing the fields of Endocrinology, Diabetes and Metabolism as well as Orthopedics and Sports Medicine. Since its inception in 2017, JBMR Plus has rapidly gained recognition within the scientific community, achieving prestigious Q1 rankings in both categories as of 2023. This esteemed journal hosts cutting-edge research, providing a platform for innovative studies that explore the intersections of bone health, metabolism, and athletic performance. With a robust Scopus ranking, where it stands in the top percentiles for its specialties, JBMR Plus aims to disseminate knowledge and foster collaborations among researchers, healthcare professionals, and students dedicated to improving patient outcomes. Researchers worldwide can access its content freely, ensuring that crucial findings reach a diverse audience, contributing significantly to the discourse in these vital medical fields.

Current Osteoporosis Reports

Empowering research to combat osteoporosis challenges.
Publisher: SPRINGERISSN: 1544-1873Frequency: 4 issues/year

Current Osteoporosis Reports, published by Springer, is a premier journal dedicated to advancing the understanding of osteoporosis and related metabolic bone diseases. With its ISSN 1544-1873 and E-ISSN 1544-2241, this esteemed publication has established itself as a vital resource in the field of endocrinology, diabetes, and metabolism, evidenced by its Q1 ranking and 82nd percentile in Scopus. Spanning from 2003 to 2024, the journal seeks to disseminate high-quality research, critical reviews, and comprehensive reports that address the complexities of osteoporosis, offering insights into diagnosis, treatment, and prevention strategies. Although not an open-access journal, Current Osteoporosis Reports ensures that researchers, healthcare professionals, and students have access to cutting-edge scientific knowledge that fuels innovative approaches to improving patient care and outcomes. The journal's impact in shaping the dialogue and research landscape in its domain underscores its importance for anyone invested in improving bone health.

Actualizaciones en Osteologia

Elevating Standards in Bone Health Research
Publisher: ASOC ARGENTINA OSTEOLOGIA & METABOLISMO MINERALISSN: 1669-8975Frequency: 3 issues/year

Actualizaciones en Osteología is a peer-reviewed academic journal dedicated to the dissemination of pivotal research in the field of osteoporosis and mineral metabolism. Published by ASOCIACIÓN ARGENTINA DE OSTEOLOGÍA & METABOLISMO MINERAL, this journal serves as a vital resource for professionals, researchers, and students in medicine, particularly within the subdomains of endocrinology, orthopedics, and radiology. With its ISSN 1669-8975 and E-ISSN 1669-8983, the journal has been operational since 2009 and is located in Córdoba, Argentina. Its increasing relevance is underscored by its categorization in the Q4 quartile across multiple medical disciplines, indicating a committed effort to enhance knowledge in these areas. Although it operates without an open-access model, the journal provides critical insights and updates that are making a significant impact in the evolving landscape of osteology and related fields. By participating in the discussions presented, contributors and readers alike can stay abreast of the latest innovations and research findings in bone health.

Modern Rheumatology

Unveiling the Latest in Rheumatology Science
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Journal of Clinical Medicine

Fostering global collaboration in medical research.
Publisher: MDPIISSN: Frequency: 24 issues/year

The Journal of Clinical Medicine is a premier peer-reviewed open-access journal published by MDPI, based in Switzerland. Since its inception in 2012, the journal has carved a niche for itself in the field of medicine, evidenced by its impressive ranking in the 2023 Scopus Ranks, where it stands at #80 out of 636 in General Medicine, placing it in the top 87th percentile. It endeavors to disseminate cutting-edge research that spans various disciplines within medicine, making it an invaluable resource for researchers, healthcare professionals, and students alike. With open access available since its launch, the journal ensures that significant medical findings are accessible to a global audience, fostering knowledge exchange and collaboration that is essential in today's rapidly evolving healthcare landscape. The journal's dedication to quality and innovation is further highlighted by its Q1 classification in the 2023 category quartiles for Medicine (miscellaneous), underlining its commitment to advancing clinical knowledge and practice.

Bone Reports

Unlocking the secrets of musculoskeletal wellness.
Publisher: ELSEVIERISSN: 2352-1872Frequency: 2 issues/year

Bone Reports is a premier, peer-reviewed journal published by Elsevier that has been committed to advancing the field of orthopedics, sports medicine, and endocrinology since its inception as an open-access journal in 2015. With an ISSN of 2352-1872, this esteemed publication seeks to disseminate high-quality research that spans a diverse array of topics related to bone health, metabolic diseases, and musculoskeletal disorders. The journal boasts an impressive impact factor, contributing significantly to its recognition, with a Q2 ranking in Orthopedics and Sports Medicine and a Q3 ranking in Endocrinology, Diabetes, and Metabolism as of 2023. This open-access model enhances accessibility and engagement, allowing researchers, professionals, and students alike to stay at the forefront of developments in these critical areas. With an emphasis on rigorous methodology and innovative findings, Bone Reports is poised to become a vital resource for anyone interested in the latest advances in bone research and clinical applications.

IRISH JOURNAL OF MEDICAL SCIENCE

Where Cutting-Edge Research Meets Clinical Relevance.
Publisher: SPRINGER LONDON LTDISSN: 0021-1265Frequency: 4 issues/year

Irish Journal of Medical Science is a distinguished peer-reviewed journal dedicated to advancing the field of medicine with a broad scope that encompasses various specialties within medical science. Published by Springer London Ltd, the journal has been a cornerstone of medical literature since its inception in 1922 and continues to impact the field with high-quality research. With an impressive impact factor and a current Scopus rank of #142 in General Medicine, placing it in the 77th percentile, the journal is recognized for its significant contribution to medical knowledge and practice. It holds a Q2 ranking in the Medicine (miscellaneous) category, highlighting its visibility and influence in the academic community. Though primarily subscription-based, the journal facilitates access to cutting-edge medical research and discussions that are crucial for researchers, health professionals, and students. By providing a platform for innovative studies and clinical advancements, the Irish Journal of Medical Science plays a vital role in shaping the future of healthcare and medical education.

Turk Osteoporoz Dergisi-Turkish Journal of Osteoporosis

Pioneering insights into osteoporosis for global health.
Publisher: GALENOS PUBL HOUSEISSN: 2147-2653Frequency: 3 issues/year

Turk Osteoporoz Dergisi - Turkish Journal of Osteoporosis, published by GALENOS PUBL HOUSE, is a vital resource for researchers and practitioners in the field of endocrinology, diabetes, and metabolism, with a specific focus on osteoporosis. Since its inception as an open-access journal in 2002, it serves to disseminate significant findings and advancements in osteoporosis research, enabling wider access to knowledge in a critical area of health that affects millions worldwide. Despite earning a Q4 categorization in 2023 within its relevant quartile ranks and being positioned at the 7th percentile among its peers in Scopus’ Endocrinology, Diabetes, and Metabolism rankings, the journal actively contributes to the dialogue on osteoporosis, covering essential topics from pathophysiology to treatment strategies. Researchers and professionals can access its contents freely, promoting collaboration and innovation in this dynamic field of study. With an ISSN of 2147-2653, this journal continues to pave the way for improved understanding and management of osteoporosis, making it a cornerstone publication for both seasoned experts and emerging scholars in Turkey and beyond.

Acta Otorrinolaringologica Espanola

Exploring the forefront of ear, nose, and throat research.
Publisher: ELSEVIER ESPANA SLUISSN: 0001-6519Frequency: 6 issues/year

Acta Otorrinolaringologica Espanola, published by Elsevier Espana SLU, is a leading journal in the field of Otorhinolaryngology, dedicated to advancing the understanding and treatment of ear, nose, and throat disorders. With a history dating back to 1973 and an established reputation for rigorously peer-reviewed research, this journal plays a pivotal role in disseminating significant findings to both clinicians and researchers. Although it is currently categorized in the Q3 quartile for 2023, ranking 72 out of 123 in its field, it serves as a vital platform for the exploration of innovative concepts and clinical practices, contributing to a deeper understanding of otolaryngological issues. While the journal is not open access, it continues to attract a wide readership due to its comprehensive articles and impactful studies. Positioned in Barcelona, Spain, this journal provides a critical resource for professionals and scholars aiming to enhance their knowledge and improve clinical outcomes in Otorhinolaryngology.